Anyone care to shed light on what is happening with this stock. It's surely a stepping stone to bigger things given the newsflow is still to come.
I think at this level it's starting to look like the cacthup is done. They'll have to back it soon with news and I'm sure they will.
They'll raise. and then they'll let it consolidate, then it will run again. Only a few month to go and they'll have approval for use in australia and ready a launch here. Christmas will be fda approval and given they already had the wheezemeter clearance i can;t see why this won't go through as planned (albeit with the usual argy bargy)
My question. What price isonea with FDA approval, a commercial partner and a launch date in the US???
and this all before the ops expire.
Add to My Watchlist
What is My Watchlist?